Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Deltagen Inc. (NasdaqNM:DGEN)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Research | SEC | Msgs | Insider | Financials | Reports
Location
1003 Hamilton Avenue
Menlo Park, CA 94025
Phone: (650) 752-0200
Fax: (650) 752-0202
Email: info@deltagen.com
Employees (last reported count): 212
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Analyst Upgrade/Downgrade History
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Biotechnology & Drugs
Company Websites
 ·Home Page
 ·Employment
 ·Products & Services
 ·Yahoo! Category

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 83%
·Over the last 6 months:
 · one insider buy; 0  shares
·Institutional: 70% (418% of float)
(44 institutions)
·Net Inst. Buying: 7.57M shares (+25.84%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Deltagen Inc. is a provider of genomics-based information, products and programs that are used to discover drug targets and drug candidates, and to accelerate pharmaceutical and biotechnology drug and product development. The Company researches, develops and uses technologies that build upon its technology platforms to discover the function, role, usefulness and disease relevance of mammalian genes and secreted proteins in drug discovery and development. The Company has developed and plans to continue to develop technologies, products and programs that determine the function and disease relevance of genes in mammalian organisms.
More from Market Guide: Expanded Business Description

Financial Summary
Deltagen Inc. develops technology that converts raw genetic data into mammalian gene function information to help pharmaceutical and biotechnology companies expedite the drug discovery process. For the six months ended 6/30/01, sales rose from $554 thousand to $5.2 million. Net loss applicable to Common fell 51% to $18.9 million. Revenues reflect higher sales from the DeltaBase mammalian gene function database. Lower loss reflects the absence of $22.4 million in preferred dividends.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY2000 Compensation
PayExer

William Matthews, Ph.D., 46
Pres, CEO, Director
$318K--  
Richard Hawkins
CFO
--  --  
Augustine Yee
VP of Corp. Devel., Gen. Counsel and Sec.
236K$288K
Kay Slocum
VP of HR
--  --  
John Burke, 39
VP of Intellectual Property
228K--  
Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year.
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NasdaqNM:DGENAs of 31-Aug-2001
Price and Volume
52-Week Low
on 27-Apr-2001
$4.00 
Recent Price$6.86 
52-Week High
on 5-Sep-2000
$32.00 
Daily Volume (3-month avg)55.5K
Daily Volume (10-day avg)106.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y]
52-Week Change-76.3%
52-Week Change
relative to S&P500
-68.3%
Share-Related Items
Market Capitalization$211.6M
Shares Outstanding30.8M
Float5.20M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq)$3.15 
Earnings (ttm)-$1.36 
Earnings (mrq)-$0.41 
Sales (ttm)$0.26 
Cash (mrq)$3.44 
Valuation Ratios
Price/Book (mrq)2.18 
Price/EarningsN/A 
Price/Sales (ttm)26.89 
Income Statements
Sales (ttm)$6.71M
EBITDA (ttm)-$32.0M
Income available to common (ttm)-$35.0M
Profitability
Profit MarginN/A 
Operating MarginN/A 
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)-33.43%
Return on Equity (ttm)-43.67%
Financial Strength
Current Ratio (mrq)6.47 
Debt/Equity (mrq)0.07 
Total Cash (mrq)$102.5M
Short Interest
As of 8-Aug-2001
Shares Short181.0K
Percent of Float3.5%
Shares Short
(Prior Month)
223.0K
Short Ratio4.89 
Daily Volume37.0K
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.